Publications
-
A brief history of oxytocin and its role in modulating psychostimulant effects.
Carson DS,
Guastella AJ, Taylor ER, McGregor IS.
J Psychopharmacol.
2013;
27
(3):
231-47
-
Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users.
Carson DS,
Bosanquet DP, Carter CS, Pournajafi-Nazarloo H, Blaszczynski A, McGregor IS.
Exp Clin Psychopharmacol.
2012;
20
(6):
497-503
-
Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats.
Bowen MT,
Carson DS, Spiro A, Arnold JC, McGregor IS.
PLoS One.
2011;
6
(11):
e27237
-
Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans.
Guastella AJ,
Kenyon AR, Alvares GA, Carson DS, Hickie IB.
Biol Psychiatry.
2010;
67
(12):
1220-2
-
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
Carson DS,
Cornish JL, Guastella AJ, Hunt GE, McGregor IS.
Neuropharmacology.
2010;
58
(1):
38-43
-
Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.
Carson DS,
Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, Boucher AA, McGregor IS.
Addict Biol.
2010;
15
(4):
448-63
-
A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
Guastella AJ,
Howard AL, Dadds MR, Mitchell P, Carson DS.
Psychoneuroendocrinology.
2009;
34
(6):
917-23
-
Does oxytocin influence the early detection of angry and happy faces?
Guastella AJ,
Carson DS, Dadds MR, Mitchell PB, Cox RE.
Psychoneuroendocrinology.
2009;
34
(2):
220-5